tiprankstipranks
Trending News
More News >
STELLA PHARMA CORPORATION (JP:4888)
:4888
Japanese Market

STELLA PHARMA CORPORATION (4888) Income Statement

Compare
0 Followers

STELLA PHARMA CORPORATION Income Statement

Last quarter (Q3 2024), STELLA PHARMA CORPORATION's total revenue was ¥85.00M, an increase of 83.99% from the same quarter last year. In Q3, STELLA PHARMA CORPORATION's net income was ¥-105.00M. See STELLA PHARMA CORPORATION’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 961.06M¥ 269.49M¥ 229.07M¥ 100.10M¥ 205.97M
Gross Profit
¥ 811.03M¥ 217.49M¥ 206.94M¥ 84.86M¥ 181.78M
Operating Expenses
¥ 901.27M¥ 977.60M¥ 1.01B¥ 826.76M¥ 862.34M
Depreciation and Amortization
¥ 34.72M¥ 35.04M¥ 35.05M¥ 34.13M¥ 31.45M
EBITDA
¥ -99.06M¥ -723.85M¥ -738.34M¥ -726.86M¥ -621.70M
Operating Income
¥ -90.25M¥ -760.30M¥ -806.77M¥ -741.90M¥ -680.57M
Other Income/Expenses
¥ -47.62M¥ -676.00K¥ 30.80M¥ -22.19M¥ 24.18M
Pretax Income
¥ -137.87M¥ -760.98M¥ -775.97M¥ -764.09M¥ -656.39M
Net Income
¥ -140.81M¥ -763.75M¥ -778.82M¥ -767.72M¥ -659.24M
Per Share Metrics
Basic EPS
¥ -4.22¥ -24.66¥ -26.97¥ -27.34¥ -32.90
Diluted EPS
¥ -4.22¥ -24.66¥ -26.97¥ -27.34¥ -32.90
Weighted Average Shares Outstanding
33.38M 30.98M 28.88M 28.08M 20.03M
Weighted Average Shares Outstanding (Diluted)
33.38M 30.98M 28.88M 28.08M 20.03M
Currency in JPY

STELLA PHARMA CORPORATION Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis